Canada Nuclear Medicine Market Size, Share & Trends Report

Canada Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostic, Therapeutic), By Application (Oncology, Bone Metastasis, Neurology, Cardiology), By End-use (Hospitals & Clinics, Diagnostic Centers), By Province, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-4-68040-167-2
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Canada Nuclear Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Diagnostic Products
      • SPECT
        • TC-99m
        • TL-201
        • GA-67
        • I-123
        • Other SPECT Products
      • PET
        • F-18
        • SR-82/RB-82
        • Other PET Products
    • Therapeutic Products
      • Alpha Emitters
        • RA-223
        • Others
      • Beta Emitters
        • I-131
        • Y-90
        • SM-153
        • Re-186
        • Lu-117
        • Other Beta Emitters
      • Brachytherapy
        • Cesium-131
        • Iodine-125
        • Palladium-103
        • Iridium-192
        • Other Brachytherapy Products
  • Canada Nuclear Medicine Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Cardiology
    • Neurology
    • Oncology
    • Thyroid
    • Lymphoma
    • Bone Metastasis
    • Endocrine Tumor
    • Others
  • Canada Nuclear Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals and Clinics
    • Diagnostic Centers
    • Others
  • Canada Nuclear Medicine Province Outlook (Revenue, USD Million, 2018 - 2030)
    • Alberta
      • Alberta Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
        • Diagnostic Products
          • SPECT
            • TC-99m
            • TL-201
            • GA-67
            • I-123
            • Other SPECT products
          • PET
            • F-18
            • SR-82/RB-82
            • Other PET Products
        • Therapeutic Products
          • Alpha Emitters
            • RA-223
            • Others
          • Beta Emitters
            • I-131
            • Y-90
            • SM-153
            • Re-186
            • Lu-117
            • Other Beta Emitters
          • Brachytherapy
            • Cesium-131
            • Iodine-125
            • Palladium-103
            • Iridium-192
            • Other Brachytherapy Products
      • Alberta Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
        • Cardiology
        • Neurology
        • Oncology
        • Thyroid
        • Lymphoma
        • Bone Metastasis
        • Endocrine Tumor
        • Others
      • Alberta Nuclear Medicine Market, By End Use, 2018 - 2030 (USD Million)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Others
    • Saskatchewan
      • Saskatchewan Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
        • Diagnostic Products
          • SPECT
            • TC-99m
            • TL-201
            • GA-67
            • I-123
            • Other SPECT products
          • PET
            • F-18
            • SR-82/RB-82
            • Other PET Products
        • Therapeutic Products
          • Alpha Emitters
            • RA-223
            • Others
          • Beta Emitters
            • I-131
            • Y-90
            • SM-153
            • Re-186
            • Lu-117
            • Other Beta Emitters
          • Brachytherapy
            • Cesium-131
            • Iodine-125
            • Palladium-103
            • Iridium-192
            • Other Brachytherapy Products
      • Saskatchewan Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
        • Cardiology
        • Neurology
        • Oncology
        • Thyroid
        • Lymphoma
        • Bone Metastasis
        • Endocrine Tumor
        • Others
      • Saskatchewan Nuclear Medicine Market, By End Use, 2018 - 2030 (USD Million)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Others
    • Manitoba
      • Manitoba Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
        • Diagnostic Products
          • SPECT
            • TC-99m
            • TL-201
            • GA-67
            • I-123
            • Other SPECT products
          • PET
            • F-18
            • SR-82/RB-82
            • Other PET Products
        • Therapeutic Products
          • Alpha Emitters
            • RA-223
            • Others
          • Beta Emitters
            • I-131
            • Y-90
            • SM-153
            • Re-186
            • Lu-117
            • Other Beta Emitters
          • Brachytherapy
            • Cesium-131
            • Iodine-125
            • Palladium-103
            • Iridium-192
            • Other Brachytherapy Products
      • Manitoba Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
        • Cardiology
        • Neurology
        • Oncology
        • Thyroid
        • Lymphoma
        • Bone Metastasis
        • Endocrine Tumor
        • Others
      • Manitoba Nuclear Medicine Market, By End Use, 2018 - 2030 (USD Million)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Others
    • Rest of Canada
      • Rest of Canada Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
        • Diagnostic Products
          • SPECT
            • TC-99m
            • TL-201
            • GA-67
            • I-123
            • Other SPECT products
          • PET
            • F-18
            • SR-82/RB-82
            • Other PET Products
        • Therapeutic Products
          • Alpha Emitters
            • RA-223
            • Others
          • Beta Emitters
            • I-131
            • Y-90
            • SM-153
            • Re-186
            • Lu-117
            • Other Beta Emitters
          • Brachytherapy
            • Cesium-131
            • Iodine-125
            • Palladium-103
            • Iridium-192
            • Other Brachytherapy Products
      • Rest of Canada Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
        • Cardiology
        • Neurology
        • Oncology
        • Thyroid
        • Lymphoma
        • Bone Metastasis
        • Endocrine Tumor
        • Others
      • Rest of Canada Nuclear Medicine Market, By End Use, 2018 - 2030 (USD Million)
        • Hospitals & Clinics
        • Diagnostic Centers
        • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon